News

Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

in Local

Illinois Video Gambling Revenue Doubles in Second Year

slot_machine

The state made nearly $165 million in 2014 from video gambling

in Local

Durbin: Consolidate 15 Federal Food Agencies Into One

food 2

U.S. Sen. Dick Durbin (D-Ill.) says he hopes the fifth time’s the charm for legislation to create a new food safety agency.

in Local

A Huge Benefit for a Taylorville Elementary School

foodbank

"Kids are well fed, happy, smiling and being themselves rather than being in a situation where their stomachs are empty, they have headaches and stomach aches, they may be nauseous."

in Local

Rockford Facility for Juvenile Wards Closes

DCFS-Logo

A facility that houses wards of the state in Rockford is closing following a newspaper's reports of assault and other issues.

in Local

Banner Year for SPI — Now What?

airport

Springfield's Abraham Lincoln Capital Airport had one of its best years ever for passenger flights last year -- so what's next?